Global Alpha Dumps 229,000 Ani Pharmaceuticals (ANIP) Shares Worth $17.9 Million
2026-05-11 17:29:29 ET
According to a Securities and Exchange Commission (SEC) filing dated May 11, 2026, Global Alpha Capital Management Ltd. sold 228,895 shares of Ani Pharmaceuticals (NASDAQ:ANIP) in the first quarter. The estimated transaction value was $17.87 million, calculated using the period's average closing price. The position's quarter-end value decreased by $18.81 million, a figure that incorporates both trading activity and price changes.
ANI Pharmaceuticals is a specialty and generic drug manufacturer with a diversified portfolio targeting high-value therapeutic categories. The company leverages its manufacturing capabilities and product development expertise to address complex formulations and niche market needs. Its integrated approach and broad distribution network provide a competitive advantage in the North American pharmaceutical market.
NASDAQ: ANIP
ANIP Trading
1.77% G/L:
$80.49 Last:
86,712 Volume:
$79.77 Open:
